Find therapies in clinical trials near you – page 65

Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

Study of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy

Study of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy

Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

Study Comparing Savolitinib and Osimertinib with Chemotherapy for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation and MET Overexpression

Study of Trastuzumab Deruxtecan for Patients with Metastatic or Unresectable HER2 Expressing Tumors

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer